COMPARE · Reviewed July 2, 2026
CVSA vs EDU
Verdict: Side-by-side breakdown using the Bull Rankings model. CVSA scored 81.4, EDU scored 77.4 — CVSA ahead by 4.
CVSA
Covista Inc.
81.4
$129.88
Score gap
4
CVSA leads
EDU
New Oriental Education & Technology Group Inc.
77.4
$47.03
The companies
CVSACovista Inc.
Why now
Education & Training Services · market cap $4.4b. 17% off the 52-week high of $156.26. Revenue growing +13%, comfortably above the S&P median. PEG 0.88 — paying under fair value for the growth rate. 4 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $156.25 (implying +20% upside).
Moat
Net margin 12% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 144% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
EDUNew Oriental Education & Technology Group Inc.
Why now
Education & Training Services · market cap $7.8b. Down 28% from 52-week high of $64.97 — deep drawdown territory. Revenue growing +14%, comfortably above the S&P median. PEG 0.79 — paying under fair value for the growth rate. 21 sell-side analysts rate this a Buy with a mean 1-yr target of $70.61 (implying +50% upside).
Moat
ROE 10% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 176% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Base grades (each contributes ~14.3% of base composite)
| CVSA | Component | EDU |
|---|---|---|
| C65 | FCF | C+70 |
| B+85 | Rev | B+85 |
| B+85 | D/E | A-90 |
| B80 | P/E or P/S | B+85 |
| B+85 | PEG | A-90 |
| Supplemental signals · feed the score, not on the row card | ||
| A-90 | FCF Yield | A-90 |
| B+85 | ROE | B80 |
| 82.5 | Base composite | 84.7 |
Adjustments (signed deltas applied on top of base)
CVSA
compounder synergy (FCF yield ≥5% + ROE ≥15% + D/E <1)+4
GARP sweet spot (PEG <1, positive FCF)+1
DCF cross-check (avg upside 92%)+1
Total+6
EDU
GARP sweet spot (PEG <1, positive FCF)+1
analyst consensus bullish (81% buy/strong-buy)+2
covered yield (2.5% at 22% payout)+1
forward P/E cheaper (17 → 11)+1
DCF cross-check (avg upside 99%)+1
Total+6
DCF cross-check (per-share value vs. live price)
| CVSA upside | Horizon | EDU upside |
|---|---|---|
| +70% | 1Y | +46% |
| +88% | 5Y | +86% |
| +117% | 10Y | +165% |
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.